# RGS5

## Overview
RGS5 (Regulator of G protein signaling 5) is a gene that encodes a member of the regulator of G protein signaling (RGS) family, which functions as a GTPase-activating protein (GAP) for G protein-coupled receptors (GPCRs). The RGS5 protein plays a crucial role in modulating GPCR signaling pathways by accelerating the deactivation of G proteins, thereby influencing the duration and intensity of signaling events. It is particularly significant in vascular biology, where it is expressed in pericytes and vascular smooth muscle cells, contributing to blood vessel maturation and stability (Mitchell2007RGS5; Bondjers2003Transcription). Additionally, RGS5 is involved in the repression of Sonic Hedgehog (Shh) signaling, impacting developmental processes and osteogenesis (Mahoney2013Regulator). The gene's expression and function have been linked to various clinical conditions, including cardiovascular diseases and cancer, highlighting its potential as a therapeutic target (Li2019Downregulated; Hamzah2008Vascular).

## Function
RGS5 (Regulator of G protein signaling 5) is a protein that plays a significant role in modulating G protein-coupled receptor (GPCR) signaling pathways by acting as a GTPase-activating protein (GAP). This activity accelerates the deactivation of G proteins, thereby regulating the duration and intensity of signaling events. RGS5 is involved in the repression of Sonic Hedgehog (Shh) signaling, a pathway crucial for various developmental processes. It functions downstream of the Smoothened (Smo) receptor, inhibiting Shh-mediated signaling and osteogenesis in certain cell types (Mahoney2013Regulator).

In vascular biology, RGS5 is expressed in pericytes and vascular smooth muscle cells, where it influences blood vessel maturation and stability. It is specifically expressed in pericytes of angiogenic vessels, playing a role in pericyte recruitment and association with endothelial cells, which is essential for vascular maturation and stabilization (Mitchell2007RGS5; Bondjers2003Transcription). RGS5 expression is upregulated during the developmental period when nascent vessel sprouts acquire pericyte coverage, highlighting its importance in angiogenesis (Mitchell2007RGS5). The protein's expression is also associated with the regulation of endothelial inflammation, potentially by modulating NF-κB signaling pathways (Li2019Downregulated).

## Clinical Significance
Alterations in the expression or function of the RGS5 gene have been implicated in several diseases, particularly cardiovascular disorders and cancer. In coronary artery disease (CAD), downregulation of RGS5 due to genetic variants impairs endothelial cell function, contributing to the pathogenesis of atherosclerosis. This downregulation is associated with the activation of the NF-κB signaling pathway, leading to increased endothelial inflammation and vascular remodeling (Li2019Downregulated).

In the context of cancer, RGS5 is overexpressed in aberrant tumor vasculature, influencing vascular morphology and immune cell infiltration. In RGS5-deficient mice, tumor vasculature normalization occurs, enhancing immune cell infiltration and potentially improving therapeutic outcomes (Hamzah2008Vascular). In breast cancer, particularly triple-negative breast cancers, high RGS5 expression is linked to increased tumor vasculature and a pro-inflammatory phenotype in vascular smooth muscle cells, promoting tumor invasion and metastasis (Kong2023RGS5).

RGS5 also plays a role in neuroinflammation, particularly in Parkinson's disease, where it enhances tumor necrosis factor receptor signaling in astrocytes, promoting neurodegeneration. Alterations in RGS5 expression can switch astrocytes from a neuroprotective to a pro-inflammatory state, exacerbating neuroinflammatory responses (Yin2023RGS5).

## Interactions
RGS5 interacts with several proteins, playing a significant role in various signaling pathways. It is known to interact with components of the Hedgehog (Hh) signaling pathway, specifically with Smoothened (Smo), a GPCR involved in Sonic Hedgehog (Shh)-mediated signaling. RGS5 is present in primary cilia and interacts with acetylated tubulin, but not with β-tubulin, indicating a specific interaction within the Hh signaling pathway (Mahoney2013Regulator). This interaction suggests that RGS5 acts as a repressor of Hh signaling by inhibiting Smo-mediated G-protein coupling to downstream effector pathways (Mahoney2013Regulator).

RGS5 also interacts with GPSM3, a protein that selectively binds to RGS5, enhancing its GTPase-activating protein (GAP) activity. This interaction is specific, as GPSM3 does not bind with other RGS proteins like RGS2, RGS4, or RGS16. The binding of RGS5 to GPSM3 enhances the rate of GTP hydrolysis by Gαi1, suggesting a regulatory role in G protein activity (Zhao2015Regulation). These interactions highlight RGS5's involvement in modulating GPCR signaling pathways and its potential impact on cellular processes such as vascular remodeling and cancer development.


## References


[1. (Hamzah2008Vascular) Juliana Hamzah, Manfred Jugold, Fabian Kiessling, Paul Rigby, Mitali Manzur, Hugo H. Marti, Tamer Rabie, Sylvia Kaden, Hermann-Josef Gröne, Günter J. Hämmerling, Bernd Arnold, and Ruth Ganss. Vascular normalization in rgs5-deficient tumours promotes immune destruction. Nature, 453(7193):410–414, April 2008. URL: http://dx.doi.org/10.1038/nature06868, doi:10.1038/nature06868. This article has 463 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/nature06868)

[2. (Zhao2015Regulation) Peishen Zhao and Peter Chidiac. Regulation of rgs5 gap activity by gpsm3. Molecular and Cellular Biochemistry, 405(1–2):33–40, April 2015. URL: http://dx.doi.org/10.1007/s11010-015-2393-3, doi:10.1007/s11010-015-2393-3. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s11010-015-2393-3)

[3. (Mitchell2007RGS5) Tracy S. Mitchell, John Bradley, Gregory S. Robinson, David T. Shima, and Yin-Shan Ng. Rgs5 expression is a quantitative measure of pericyte coverage of blood vessels. Angiogenesis, 11(2):141–151, November 2007. URL: http://dx.doi.org/10.1007/s10456-007-9085-x, doi:10.1007/s10456-007-9085-x. This article has 75 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1007/s10456-007-9085-x)

[4. (Mahoney2013Regulator) William M. Mahoney, Jagadambika Gunaje, Guenter Daum, Xiu Rong Dong, and Mark W. Majesky. Regulator of g-protein signaling – 5 (rgs5) is a novel repressor of hedgehog signaling. PLoS ONE, 8(4):e61421, April 2013. URL: http://dx.doi.org/10.1371/journal.pone.0061421, doi:10.1371/journal.pone.0061421. This article has 10 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0061421)

[5. (Kong2023RGS5) Peng Kong, Xu Wang, Ya-Kun Gao, Dan-Dan Zhang, Xiao-Fu Huang, Yu Song, Wen-Di Zhang, Rui-Juan Guo, Han Li, and Mei Han. Rgs5 maintaining vascular homeostasis is altered by the tumor microenvironment. Biology Direct, November 2023. URL: http://dx.doi.org/10.1186/s13062-023-00437-y, doi:10.1186/s13062-023-00437-y. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s13062-023-00437-y)

[6. (Bondjers2003Transcription) Cecilia Bondjers, Mattias Kalén, Mats Hellström, Stefan J. Scheidl, Alexandra Abramsson, Oliver Renner, Per Lindahl, Hyeseon Cho, John Kehrl, and Christer Betsholtz. Transcription profiling of platelet-derived growth factor-b-deficient mouse embryos identifies rgs5 as a novel marker for pericytes and vascular smooth muscle cells. The American Journal of Pathology, 162(3):721–729, March 2003. URL: http://dx.doi.org/10.1016/s0002-9440(10)63868-0, doi:10.1016/s0002-9440(10)63868-0. This article has 193 citations.](https://doi.org/10.1016/s0002-9440(10)63868-0)

[7. (Yin2023RGS5) Shu Yin, Xin-yue Ma, Ying-feng Sun, Yan-qing Yin, Ying Long, Chun-lai Zhao, Jun-wei Ma, Sen Li, Yan Hu, Ming-tao Li, Gang Hu, and Jia-wei Zhou. Rgs5 augments astrocyte activation and facilitates neuroinflammation via tnf signaling. Journal of Neuroinflammation, September 2023. URL: http://dx.doi.org/10.1186/s12974-023-02884-w, doi:10.1186/s12974-023-02884-w. This article has 6 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s12974-023-02884-w)

[8. (Li2019Downregulated) Yang Li, Han Yan, Jian Guo, Yingchun Han, Cuifang Zhang, Xiuying Liu, Jie Du, and Xiao-Li Tian. Down-regulated rgs5 by genetic variants impairs endothelial cell function and contributes to coronary artery disease. Cardiovascular Research, 117(1):240–255, October 2019. URL: http://dx.doi.org/10.1093/cvr/cvz268, doi:10.1093/cvr/cvz268. This article has 15 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1093/cvr/cvz268)